MAPS Publish January Newsletter 2023

Here’s their latest updates.. the world according to MAPS

MAPS Featured in Major Media

Our psychedelic research has received major media coverage in the past month. MAPS Founder and Executive Director Rick Doblin, Ph.D, was featured on Fox Business with Kennedy. Articles featuring MAPS ran in publications including The Intercept, High Times, and Benzinga.

Visit our MAPS in the Media webpage to view all media articles about our work.

New Speakers Announced for Psychedelic Science 2023

More speakers have been confirmed for Psychedelic Science 2023! You can view the full list of speakers on the PS2023 website.

Psychedelic Science 2023 takes place June 19-23, 2023, in Denver, Colorado, and is the largest psychedelic gathering in the world. Sign up for exclusive email updates to receive the latest news, or visit our website to explore the agenda or book a hotel to secure the best rates.

Psychedelic Fundamentals: Give the Gift of Learning

Psychedelic Fundamentals, the introductory course in the MAPS Digital Learning series, will guide you through the basics of psychedelics via a series of short, easy-to-follow lessons. The course takes just a few hours and provides you with an overview of the most interesting and important aspects of psychedelic history, science, clinical research, therapeutic uses, and harm reduction, backed by over 36 years of MAPS history as a leading institution for psychedelic education. Use code HTCYM for 25% off registration for Psychedelic Fundamentals for yourself or your psychedelically curious friends!

In-depth courses on integration, peer support, and more are available for pre-order now. Order today for $80 in savings on each course…the discount only lasts until the courses are launched!

Register Now
MAPS, MAPS PBC, and MAPS Europe are Hiring
View our careers page to apply for one of our many open job positions or refer a friend! All of our organizations — MAPS, MAPS Public Benefit Corporation, and MAPS Europe — are hiring for full-time roles from development to clinical science to regulatory compliance.

Treating PTSD with MDMA-Assisted Therapy


Prior Positive Results Confirmed in Phase 3 Trial of MDMA-Assisted Therapy for PTSD (MAPP2)

MDMA Therapy Training Program Update: January 2023


MAPS in the Media

Primary Sponsor


Karma Koala Podcast

Top Marijuana Blog